About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Nextgen
Biotechnology Developments
Betuvax
Histograft
Genotarget
Reprobank
Vitacel
24.09.2025
Press releases
Artgen Biotech Partners with the University of Entrepreneurs
22.09.2025
Press releases
Gemabank Will Pay Dividends for 6 Months of 2025
01.09.2025
News
Russian Gene Therapy Drug Presented at the Asian Society of Vascular Surgeons
29.08.2025
Press releases
Artgen Biotech’s IFRS Results for 6 Months of 2025
26.08.2025
Press releases
Genetico’s Board of Directors Appoints New Company Head
14.08.2025
Press releases
Gemabank’s Board of Directors Recommends Dividends for 6 Months of 2025
13.08.2025
Press releases
RBT and the Almazov Center Will Develop New Medical Technologies and Products
1
…
3
4
5
6
7
…
26
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
